Breast implant-associated ALCL: A unique entity in the spectrum of CD30+ lymphoproliferative disorders

Oncologist

Volumn 18, Issue 3, 2013, Pages 301-307

  Story, Sara K ^a   Schowalter, Michael K ^a,b   Geskin, Larisa J ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Doris Duke Charitable Foundation   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Anaplastic large cell lymphoma; Anaplastic lymphoma kinase; Breast implant

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CARBOPLATIN; CD30 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; METHYLPREDNISOLONE; NAVELBINE; PREDNISOLONE; VINCRISTINE;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BREAST IMPLANT; CANCER RECURRENCE; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; LARGE CELL LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION; SURVIVAL RATE; SYSTEMATIC REVIEW;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD30; BREAST IMPLANTATION; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED;

EID: 84875415200     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0238     Document Type: Article

References (52)

1. Bishara MR, Ross C, Sur M. Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: An unusual case presentation. Diagn Pathol 2009;4:11.
2. Kim B, Roth C, Chung KC et al. Anaplastic large cell lymphoma and breast implants: A systematic review. Plast Reconstr Surg 2011;127:2141-2150.
3. Wong AK, Lopategui J, Clancy S et al. Anaplastic large cell lymphoma associated with a breast implant capsule: A case report and review of the literature. Am J Surg Pathol 2008;32:1265-1268.
4. Woo DK, Jones CR, Vanoli-Storz MN et al. Prognostic factors in primary cutaneous anaplastic large cell lymphoma: Characterization of clinical subset with worse outcome. Arch Dermatol 2009;145: 667-674.
5. Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 1999:12.
6. Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 1997;100:554-555.
7. Lazzeri D, Agostini T, Bocci G et al. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: A new clinical entity. Clin Breast Cancer 2011;11:283-296.
8. Joks M, Mýliwiec K, Lewandowski K. Primary breast lymphoma-a review of the literature and report of three cases. Arch Med Sci 2011;7:27-33.
9. Mikkola ML, Millar SE. The mammary bud as a skin appendage: Unique and shared aspects of development. J Mammary Gland Biol Neoplasia 2006; 11:187-203.
10. Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: Mechanisms and clinical consequences. Nat Rev Immunol 2004;4:211-222.
11. Lowe DB, Storkus WJ. Chronic inflammation and immunologic-based constraints in malignant disease. Immunotherapy 2011;3:1265-1274.
12. Ellis TM, Simms PE, Slivnick DJ et al. CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO T cells. J Immunol 1993;151:2380-2389.
13. Kadin ME. Regulation of CD30 antigen expression and its potential significance for human disease. Am J Pathol 2000;156:1479-1484.
14. Wu Y, Zhou BP. TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion. Br J Cancer 2010; 102:639-644.
15. Levi E, Wang Z, Petrogiannis-Haliotis T et al. Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: A possible mechanism for disease progression. J Invest Dermatol 2000; 115:1034-1040.
16. Davis TH, Morton CC, Miller-Cassman R et al. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 1992;326:1115-1122.
17. Gniadecki R. Neoplastic stem cells in cutaneous lymphomas: Evidence and clinical implications. Arch Dermatol 2004;140:1156-1160.
18. Kempf W, Pfaltz K, Vermeer MH et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: Lymphomatoid papulosis and primary cutaneous anaplastic largecell lymphoma. Blood 2011;118:4024-4035.
19. Akilov OE, Pillai RK, Grandinetti LM et al. Clonal T-cell receptor-chain gene rearrangements in differential diagnosis of lymphomatoid papulosis from skin metastasis of nodal anaplastic large-cell lymphoma. Arch Dermatol 2011;147:943-947.
20. Lamant L, Pileri S, Sabattini E et al. Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: Evidence for an association in five cases. Haematologica 2010;95: 449-455.
21. Bergman R. Pseudolymphoma and cutaneous lymphoma: Facts and controversies. Clin Dermatol 2010;28:568-574.
22. Palraj B, Paturi A, Stone RG et al. Soft tissue anaplastic large T-cell lymphoma associated with a metallic orthopedic implant: Case report and review of the current literature. J Foot Ankle Surg 2010;49:561-564.
23. Duvic M, Moore D, Menter A et al. Cutaneous T-cell lymphoma in association with silicone breast implants. J Am Acad Dermatol 1995;32:939-942.
24. Alobeid B, Sevilla DW, El-Tamer MB et al. Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement. Leuk Lymphoma 2009;50:831-833.
25. Carty MJ, Pribaz JJ, Antin JH et al. A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast. Plast Reconstr Surg 2011;128:112e-118e.
26. de Jong D, Vasmel WJ, de Boer JP et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA 2008;300:2030-2035.
27. Do V, Shifrin DA, Oostendorp L. Lymphoma of the breast capsule in a silicone implant-reconstructed patient. Am Surg 2010;76:1030-1031.
28. Farkash EA, Ferry JA, Harris NL et al. Rare lymphoid malignancies of the breast: A report of two cases illustrating potential diagnostic pitfalls. J Hematop 2009;2:237-244.
29. Fritzsche FR, Pahl S, Petersen I et al. Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer-a case report. Virchows Arch 2006;449:561-564.
30. Gaudet G, Friedberg JW, Weng A et al. Breast lymphoma associated with breast implants: Two case-reports and a review of the literature. Leuk Lymphoma 2002;43:115-119.
31. Gualco G, Chioato L, Harrington WJ Jr et al. Primary and secondary T-cell lymphomas of the breast: Clinico-pathologic features of 11 cases. Appl Immunohistochem Mol Morphol 2009;17:301-306.
32. Li S, Lee AK. Silicone implant and primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction? Int J Clin Exp Pathol 2009;3: 117-127.
33. Miranda RN, Lin L, Talwalkar SS et al. Anaplastic large cell lymphoma involving the breast: A clinicopathologic study of 6 cases and review of the literature. Arch Pathol Lab Med 2009;133:1383-1390.
34. Newman MK, Zemmel NJ, Bandak AZ et al. Primary breast lymphoma in a patient with silicone breast implants: A case report and review of the literature. J Plast Reconstr Aesthet Surg 2008;61:822-825.
35. Olack B, Gupta R, Brooks GS. Anaplastic large cell lymphoma arising in a saline breast implant capsule after tissue expander breast reconstruction. Ann Plast Surg 2007;59:56-57.
36. Popplewell L, Thomas SH, Huang Q et al. Primary anaplastic large-cell lymphoma associated with breast implants. Leuk Lymphoma 2011;52: 1481-1487.
37. Roden AC, Macon WR, Keeney GL et al. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: An indolent T-cell lymphoproliferative disorder. Mod Pathol 2008;21:455-463.
38. Sahoo S, Rosen PP, Feddersen RM et al. Anaplastic large cell lymphoma arising in a silicone breast implant capsule: A case report and review of the literature. Arch Pathol Lab Med 2003;127: e115-e118.
39. Wong A, Subtil A. Secondary cutaneous involvement by breast implant-associated ALK-negative anaplastic large cell lymphoma (ALCL)-report of a case with fatal outcome. Am J Dermatopathol 2011;33:423.
40. Lazzeri D, Agostini T, Pantaloni M et al. Furtherinformation on anaplastic large cell lymphoma and breast implants. Plast Reconstr Surg 2011;128:813-815
41. Kadin ME, Xu H, Pavlov I et al. Breast implant associated ALCL closely resembles primary cutaneous ALCL. Lab Investig 2012;92(suppl 1):346A.
42. Bengtson B, Brody GS, Brown MH et al; Late Periprosthetic Fluid Collection after Breast Implant Working Group. Managing late periprosthetic fluid collections (seroma) in patients with breast implants: A consensus panel recommendation and review of the literature. Plast Reconstr Surg 2011;128: 1-7.
43. Shehan JM, Kalaaji AN, Markovic SN et al. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma. J Am Acad Dermatol 2004;51:103-110.
44. Bekkenk MW, Geelen FA, van Voorst Vader PC et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: A report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000;95:3653-3661.
45. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-28.
46. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993;9:138-141.
47. Chow M, Rubin H. Clonal selection versus genetic instability as the driving force in neoplastic transformation. Cancer Res 2000;60:6510-6518.
48. Preston-Martin S, Pike MC, Ross RK et al. Increased cell division as a cause of human cancer. Cancer Res 1990;50:7415-7421.
49. Tomlinson I, Bodmer W. Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog. Nat Med 1999;5:11-12.
50. Tomlinson IP, Novelli MR, Bodmer WF. The mutation rate and cancer. Proc Natl Acad Sci U S A 1996;93:14800-14803.
51. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
52. Querfeld C, Khan I, Mahon B et al. Primary cutaneous and systemic anaplastic large cell lymphoma: Clinicopathologic aspects and therapeutic options. Oncology 2010;24:574-587.